Qi Jing, Lian Tenghong, Guo Peng, He Mingyue, Li Jinghui, Li Jing, Luo Dongmei, Zhang Yanan, Huang Yue, Liu Gaifen, Zheng Zijing, Guan Huiying, Zhang Weijia, Yue Hao, Liu Zhan, Zhang Fan, Meng Yao, Wang Ruidan, Zhang Wenjing, Zhang Wei
Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
Center for Cognitive Neurology, Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
Front Aging Neurosci. 2024 Nov 21;16:1471698. doi: 10.3389/fnagi.2024.1471698. eCollection 2024.
Abnormal eye movements occur at the early stages of Alzheimer's disease (AD). However, the characteristics of abnormal eye movements of patients with AD and their relationship with clinical symptoms remain inconsistent, and their predictive value for diagnosing and monitoring the progression of AD remains unclear.
A total of 42 normal controls, 63 patients with mild cognitive impairment due to AD (AD-MCI), and 49 patients with dementia due to AD (AD-D) were recruited. Eye movements were assessed using the EyeKnow eye-tracking and analysis system. Cognitive function, neuropsychiatric symptoms, and activities of daily living were evaluated using various rating scales, and correlation analyses and receiver operating characteristic curves were performed.
Patients with AD exhibited increased number of offsets and offset degrees, prolonged offset duration, and decreased accuracy in lateral fixation; reduced accuracy, prolonged saccadic duration, and decreased velocity in prosaccade; decreased accuracy and corrected rate, prolonged corrected antisaccadic duration, and reduced velocity in antisaccade; and reduced accuracy and increased inhibition failures in memory saccade. Eye movement parameters were correlated with global cognition and the cognitive domains of memory, language, attention, visuospatial ability, execution function, and activities of daily living. Subgroup analysis indicated that the associations between eye movements and clinical symptoms in patients with AD were influenced by disease severity and history of diabetes. In the AD-D and AD with diabetes groups, these associations diminished. Nevertheless, the associations persisted in the AD-MCI and AD without diabetes groups. The areas under the curves for predicting AD, AD-MCI, and AD-D were 0.835, 0.737, and 0.899, respectively (all < 0.05).
Patients with AD exhibit distinct patterns of abnormal eye movements. Abnormal eye movements are significantly correlated with global cognition, multiple cognitive domains, and activities of daily living. Abnormal eye movements have a considerable predictive value for the diagnosis and progression of AD.
异常眼动出现在阿尔茨海默病(AD)的早期阶段。然而,AD患者异常眼动的特征及其与临床症状的关系仍不一致,其对AD诊断和病情进展监测的预测价值仍不明确。
共招募了42名正常对照者、63名AD所致轻度认知障碍(AD-MCI)患者和49名AD所致痴呆(AD-D)患者。使用EyeKnow眼动追踪与分析系统评估眼动。使用各种评定量表评估认知功能、神经精神症状和日常生活活动能力,并进行相关性分析和受试者工作特征曲线分析。
AD患者表现为偏移次数和偏移程度增加、偏移持续时间延长、横向注视准确性降低;前扫视准确性降低、扫视持续时间延长、速度降低;反扫视准确性和校正率降低、校正反扫视持续时间延长、速度降低;记忆扫视准确性降低、抑制失败增加。眼动参数与整体认知以及记忆、语言、注意力、视觉空间能力、执行功能等认知领域和日常生活活动能力相关。亚组分析表明,AD患者眼动与临床症状之间的关联受疾病严重程度和糖尿病史的影响。在AD-D组和患有糖尿病的AD组中,这些关联减弱。然而,在AD-MCI组和未患糖尿病的AD组中,这些关联仍然存在。预测AD、AD-MCI和AD-D的曲线下面积分别为0.835、0.737和0.899(均<0.05)。
AD患者表现出独特的异常眼动模式。异常眼动与整体认知、多个认知领域和日常生活活动能力显著相关。异常眼动对AD的诊断和病情进展具有相当大的预测价值。